Anti-anxiety drugs work by changing the balance of chemical signals in your brain, but they do it in very different ways depending on the type. Some quiet overactive nerve cells within minutes, while others gradually retune your brain’s threat-detection system over weeks. Understanding the differences helps explain why your doctor might choose one over another and why timelines for relief vary so widely.
Benzodiazepines: Fast-Acting Brain Quieters
Benzodiazepines like diazepam, lorazepam, and alprazolam are the fastest-acting anti-anxiety drugs available. They work by latching onto a specific docking site on GABA-A receptors, which are the brain’s primary “calm down” receptors. GABA is a chemical messenger whose whole job is to reduce nerve cell activity. When a benzodiazepine binds to the receptor, it doesn’t activate the receptor directly. Instead, it amplifies GABA’s natural effect, letting more chloride ions flow into nerve cells. That influx of chloride makes the neurons less likely to fire, which is why you feel calmer, more relaxed, and sometimes drowsy.
This mechanism, called positive allosteric modulation, is why benzodiazepines can provide relief within 30 to 60 minutes. It’s also why they’re typically reserved for short-term or as-needed use. The FDA requires its strongest warning label on all benzodiazepines because even when taken at recommended doses, they can lead to physical dependence within several days to weeks of steady use. Stopping abruptly or cutting the dose too quickly can trigger withdrawal reactions, including seizures. The risks climb further when benzodiazepines are combined with opioids, alcohol, or other sedating substances.
SSRIs and SNRIs: Retraining the Threat Response
The most commonly prescribed medications for long-term anxiety management aren’t traditional “anti-anxiety” drugs at all. They’re antidepressants, specifically SSRIs and SNRIs. SSRIs block the reabsorption of serotonin after it’s released between nerve cells, leaving more of it available in the gap between neurons. SNRIs do the same thing for both serotonin and norepinephrine. More serotonin circulating in key brain circuits gradually shifts how your brain processes threat and emotion.
The changes are not instant. These medications typically need four to six weeks of consistent use before you notice a meaningful reduction in anxiety. During the early days, the brain is still adjusting. Neuroimaging research shows that short-term SSRI treatment actually increases activity in the amygdala, the brain’s alarm center, and ramps up signaling in prefrontal areas involved in threat appraisal. This early increase may explain why some people feel temporarily more jittery or on edge when they first start the medication. Over time, the brain recalibrates: prefrontal control circuits strengthen their regulation of the amygdala, and the overall threat response dampens.
There’s also a deeper structural change happening beneath the surface. Chronic antidepressant treatment increases production of a growth protein called BDNF in the hippocampus, a brain region involved in memory and emotional regulation. This protein supports the survival of newly born neurons and increases the turnover of cells in ways that help the hippocampus function more effectively. Research in the Journal of Neuroscience found that antidepressants don’t simply create new neurons. They increase the overall turnover of hippocampal cells, and normal BDNF signaling is required for those new neurons to survive long-term. This remodeling process is one reason the drugs take weeks to work and why their benefits often grow over months of use.
Common side effects of SSRIs include fatigue, changes in appetite, and weight gain. SNRIs carry a similar profile, though weight loss is actually more common than weight gain with that class. Both can cause drowsiness in some people.
Buspirone: A Slower, Targeted Approach
Buspirone works differently from both benzodiazepines and antidepressants. It’s a partial agonist at the 5-HT1A serotonin receptor, meaning it activates that receptor partway rather than fully. Think of it as a dimmer switch rather than an on/off switch for serotonin signaling. By partially activating these specific receptors, buspirone helps stabilize serotonin activity without the sedation or dependence risk that comes with benzodiazepines.
The tradeoff is speed. Buspirone takes four to six weeks to reach its full therapeutic effect, similar to SSRIs. It also has a short half-life, which means it needs to be taken multiple times a day to maintain steady levels in the body. For people who need non-addictive, long-term anxiety management but don’t tolerate antidepressants well, buspirone can be a useful alternative.
Why Different Drugs for Different Situations
The choice between these medications comes down to what kind of anxiety you’re dealing with and how quickly you need relief. Benzodiazepines are effective for acute episodes, like panic attacks or intense situational anxiety, because they work almost immediately. But their dependence risk makes them a poor fit for everyday, ongoing use. SSRIs and SNRIs are better suited for generalized anxiety, social anxiety, and other chronic conditions because they gradually reshape the brain circuits driving the anxiety. Buspirone fills a middle role for generalized anxiety when dependence is a concern and antidepressants aren’t the right fit.
Some people end up using more than one class. A common approach involves starting an SSRI for long-term management while using a benzodiazepine briefly during the four-to-six-week window before the SSRI takes full effect. The benzodiazepine bridges the gap, then gets tapered off once the antidepressant is doing its job.
Side Effects Across Drug Classes
Drowsiness is the most universal side effect across nearly all anti-anxiety medications. Benzodiazepines cause it acutely and can also impair memory and coordination, especially at higher doses. SSRIs and SNRIs tend to cause fatigue and weakness, particularly in the first few weeks. Older antidepressant classes like tricyclics are more sedating and more likely to cause weight gain and memory problems, which is one reason they’ve fallen out of favor for anxiety treatment.
Weight changes vary by medication class. SSRIs can increase appetite and lead to weight gain over time. SNRIs are somewhat less likely to do so. Buspirone is generally weight-neutral. Benzodiazepines don’t directly cause weight gain, but the sedation they produce can reduce physical activity, which has its own downstream effects.
Sexual side effects are common with SSRIs and SNRIs, though less discussed. Buspirone is notably less likely to cause them, which is another reason it remains in use despite its slower onset and need for multiple daily doses.